spacer
spacer

PDBsum entry 2o4h

Go to PDB code: 
protein ligands metals Protein-protein interface(s) links
Hydrolase PDB id
2o4h

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
301 a.a. *
Ligands
AS9 ×2
Metals
_ZN ×2
Waters ×69
* Residue conservation analysis
PDB id:
2o4h
Name: Hydrolase
Title: Human brain aspartoacylase complex with intermediate analog (n- phosphonomethyl-l-aspartate)
Structure: Aspartoacylase. Chain: a, b. Synonym: aminoacylase-2, acy-2. Engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Organ: brain. Gene: aspa, acy2, asp. Expressed in: pichia pastoris. Expression_system_taxid: 4922.
Resolution:
2.70Å     R-factor:   0.205     R-free:   0.271
Authors: J.Le Coq,A.Pavlovsky,R.Sanishvili,R.E.Viola
Key ref: J.Le Coq et al. (2008). Examination of the mechanism of human brain aspartoacylase through the binding of an intermediate analogue. Biochemistry, 47, 3484-3492. PubMed id: 18293939
Date:
04-Dec-06     Release date:   06-Nov-07    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
P45381  (ACY2_HUMAN) -  Aspartoacylase from Homo sapiens
Seq:
Struc:
313 a.a.
301 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class: E.C.3.5.1.15  - aspartoacylase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: an N-acyl-L-aspartate + H2O = a carboxylate + L-aspartate
N-acyl-L-aspartate
+ H2O
= carboxylate
+
L-aspartate
Bound ligand (Het Group name = AS9)
matches with 69.23% similarity
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    reference    
 
 
Biochemistry 47:3484-3492 (2008)
PubMed id: 18293939  
 
 
Examination of the mechanism of human brain aspartoacylase through the binding of an intermediate analogue.
J.Le Coq, A.Pavlovsky, R.Malik, R.Sanishvili, C.Xu, R.E.Viola.
 
  ABSTRACT  
 
Canavan disease is a fatal neurological disorder caused by the malfunctioning of a single metabolic enzyme, aspartoacylase, that catalyzes the deacetylation of N-acetyl-L-aspartate to produce L-aspartate and acetate. The structure of human brain aspartoacylase has been determined in complex with a stable tetrahedral intermediate analogue, N-phosphonomethyl-L-aspartate. This potent inhibitor forms multiple interactions between each of its heteroatoms and the substrate binding groups arrayed within the active site. The binding of the catalytic intermediate analogue induces the conformational ordering of several substrate binding groups, thereby setting up the active site for catalysis. The highly ordered binding of this inhibitor has allowed assignments to be made for substrate binding groups and provides strong support for a carboxypeptidase-type mechanism for the hydrolysis of the amide bond of the substrate, N-acetyl- l-aspartate.
 

Literature references that cite this PDB file's key reference

  PubMed id Reference
21095151 S.Zano, R.Malik, S.Szucs, R.Matalon, and R.E.Viola (2011).
Modification of aspartoacylase for potential use in enzyme replacement therapy for the treatment of Canavan disease.
  Mol Genet Metab, 102, 176-180.  
20921362 J.M.Hsieh, K.Tsirulnikov, M.R.Sawaya, N.Magilnick, N.Abuladze, I.Kurtz, J.Abramson, and A.Pushkin (2010).
Structures of aminoacylase 3 in complex with acetylated substrates.
  Proc Natl Acad Sci U S A, 107, 17962-17967.
PDB codes: 3nfz 3nh4 3nh5 3nh8
19362172 K.Tsirulnikov, N.Abuladze, D.Newman, S.Ryazantsev, T.Wolak, N.Magilnick, M.C.Koag, I.Kurtz, and A.Pushkin (2009).
Mouse aminoacylase 3: a metalloenzyme activated by cobalt and nickel.
  Biochim Biophys Acta, 1794, 1049-1057.  
19319678 M.H.Baslow, and D.N.Guilfoyle (2009).
Are astrocytes the missing link between lack of brain aspartoacylase activity and the spongiform leukodystrophy in canavan disease?
  Neurochem Res, 34, 1523-1534.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB codes are shown on the right.

 

spacer

spacer